FIELD: chemistry.
SUBSTANCE: compound is ((S)-1-phenyl-propyl)-amide 3-(methane sulphonyl amino)-2-phenyl- quinoline-4-carboxylic acid, stereoisomer, enantiomer or pharmaceutically acceptable salt thereof. The invention also relates to a pharmaceutical composition based on the disclosed compound.
EFFECT: novel derivative of methyl sulphonamide quinoline which can be used to modulate the NK-3 receptor.
2 cl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| QUINOLINE DERIVATIVES AS TECHYCHININ NK RECEPTOR ANTAGONISTS | 1995 |
|
RU2155754C2 |
| QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND USE THEREOF | 2012 |
|
RU2610262C2 |
| NMDA RECEPTOR MODULATORS AND THEIR APPLICATION | 2012 |
|
RU2621049C2 |
| DERIVATIVES OF AMINES OR AMIDES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ANTAGONIZING RECEPTOR Y5 OF NEUROPEPTIDE NPY | 2000 |
|
RU2228927C2 |
| PYRIDOPYRIMIDINONES AND USE THEREOF AS MODULATORS OF N-METHYL-D-ASPARTATE RECEPTOR | 2016 |
|
RU2717665C2 |
| OESTROGEN RECEPTORS LIGANDS | 2012 |
|
RU2620375C9 |
| PYRASOLE[3,4-b]PYRIDINE COMPOUNDS AND THEIR APPLICATION AS PHOSPHODIESTERASE INHIBITORS | 2003 |
|
RU2348633C2 |
| PYRAZOLOPYRIDINE DERIVATIVES AS KINASE INHIBITORS | 2015 |
|
RU2733400C2 |
| PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
| MACROCYCLIC COMPOUND | 2020 |
|
RU2818822C1 |
